Literature DB >> 11037117

Sufentanil and medetomidine anaesthesia in the rat and its reversal with atipamezole and butorphanol.

P Hedenqvist1, J V Roughan, P A Flecknell.   

Abstract

Injectable anaesthetics are widely used to anaesthetize rats, but recovery times are often prolonged. Reversible anaesthetic regimens have the advantage that animals may be recovered quickly, thus reducing the incidence of postoperative complications such as hypothermia, and also providing a means of treating inadvertent anaesthetic overdose. This study assessed and compared the characteristics of anaesthesia induced with combinations of sufentanil and medetomidine administered as a single subcutaneous or intraperitoneal dose, and reversal with butorphanol and atipamezole. Combinations of sufentanil/medetomidine at 40 microg/150 microg and 50 microg/150 microg/kg administered subcutaneously, and 80 microg/300 microg/kg by intraperitoneal injection were found to produce surgical anaesthesia for 101+/-49, 124+/-45 and 76+/-23 min (means +/- SD) respectively. All three combinations produced marked respiratory depression 30 min after injection (< 50% of resting respiratory rate). Oxygen saturation, measured by pulse oximetry, was < 50% in all groups 30 min following drug administration. Subcutaneous administration is recommended since it resulted in a more reliable and more rapid induction of anaesthesia than intraperitoneal administration. The administration of butorphanol and atipamezole (0.2/0.5 mg/kg s.c.) resulted in a rapid (< 7 min) reversal of anaesthesia and an associated respiratory depression. The induction of anaesthesia with sufentanil/medetomidine and its reversal with a combination of atipamezole and butorphanol is an effective technique for anaesthetizing rats. However, due to the marked respiratory depression and the resulting hypoxia, we recommend that this regimen should only be used in animals which are free from respiratory disease and that oxygen should be provided during anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037117     DOI: 10.1258/002367700780384762

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  10 in total

1.  Anesthesia with intraperitoneal propofol, medetomidine, and fentanyl in rats.

Authors:  Heber Nuno Castro Alves; Aura Luísa Maia da Silva; Ingrid Anna S Olsson; José Manuel Gonzalo Orden; Luis Marques Antunes
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

2.  Using remifentanil in mechanically ventilated rats to provide continuous analgosedation.

Authors:  Nada M Ismaiel; Raymond Chankalal; Juan Zhou; Dietrich Henzler
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-01       Impact factor: 1.232

3.  Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL/6J mice.

Authors:  Jenelle M Izer; Tiffany L Whitcomb; Ronald P Wilson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

4.  Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Aude Castel; Denise Carrier; Francis Beaudry; Pascal Vachon
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

5.  Stem cells protect the bronchial stump in rat, increasing Sox6, Col2a1, and Agc1 expression.

Authors:  Pedro Llontop; Norberto Santana-Rodríguez; Bernardino Clavo; Ardiel Quintana; María D Fiuza; Rafael Camacho; Alfredo Santana-Rodríguez; Carlos Santana; José A Ruíz-Caballero
Journal:  Lung       Date:  2014-03-20       Impact factor: 2.584

6.  Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats.

Authors:  Maike Albrecht; Julia Henke; Sabine Tacke; Michael Markert; Brian Guth
Journal:  BMC Vet Res       Date:  2014-08-23       Impact factor: 2.741

7.  Sufentanil-medetomidine anaesthesia compared with fentanyl/fluanisone-midazolam is associated with fewer ventricular arrhythmias and death during experimental myocardial infarction in rats and limits infarct size following reperfusion.

Authors:  Ellis N Ter Horst; Paul A J Krijnen; Paul Flecknell; Klaas W Meyer; Klaas Kramer; Anja M van der Laan; Jan J Piek; Hans W M Niessen
Journal:  Lab Anim       Date:  2017-08-04       Impact factor: 2.471

8.  Comparison of the anesthetic effect by the injection route of mixed anesthesia (medetomidine, midazolam and butorphanol) and the effect of this anesthetic agent on the respiratory function.

Authors:  Hiromi Shibuta; Rei Yamana; Junko Kashimoto; Kyohei Kamio; Akiko Suda
Journal:  J Vet Med Sci       Date:  2019-11-21       Impact factor: 1.267

9.  A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice.

Authors:  Wesley M Burnside; Paul A Flecknell; Angus I Cameron; Aurélie A Thomas
Journal:  BMC Vet Res       Date:  2013-03-13       Impact factor: 2.741

10.  The effects of post-operative oxygen supply on blood oxygenation and acid-base status in rats anaesthetized with fentanyl/fluanisone and midazolam.

Authors:  Leander Gaarde; Stefanie Kolstrup; Peter Bollen
Journal:  PLoS One       Date:  2021-08-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.